Search Results for "Kowa Lilly Activation"

20:33 EDT 27th April 2015 | BioPortfolio

Matching Channels

Lilly

Eli Lilly and Company was founded in 1876, and is now the 9th largest pharmaceutical company based an annual sales which were just under $20bn in 2009. Orginally from the USA, Lilly now operates in ...

Glucagon rDNA Lilly

Insulin Pork Lilly

Insulin rDNA Lilly

Somatropin Hgh rDNA Lilly

Matching News

NIH studying Kowa's statin in HIV

The National Institutes of Health is starting a North American trial of pitavastatin from Kowa Co. Ltd. (Nagoya, Japan) to prevent cardiovascular disease in HIV patients. The double-blind, placebo-con...

Kowa American Corporation Introduces New Mobile Solutions Products in Ophthalmology

New SL-17 Handheld Portable Slit Lamp and 2WIN Binocular Autorefractometer to Display at Vision Expo East and AAPOS Annual Meeting Torrance, California (PRWEB) February 27, 2015 Kowa American Corpora...

Lilly: Announcing the 2015 REACH Lilly MDR TB Partnership Media Award Winners

SOURCE: Eli Lilly and Company DESCRIPTION:Today’s guest blog comes from Sunita Prasad, senior manager for Lilly’s MDR-TB Partnership in India. Tuberculosis (TB) continues to pose a monumental glob...

Lilly sets timelines for solanezumab

Expect Eli Lilly & Co to start giving analysts and investors some color on its Alzheimer's disease program by the end of 2016. Lilly revealed during its first quarter earnings call 23 April that the l...

Amarin: Kowa Co-Promotion Agreement May Be Boosting Sales

Lilly Foundation Furthers Commitment to Education

SOURCE: Eli Lilly and Company DESCRIPTION:Taking steps to improve the educational opportunities available to all of the children in our hometown of Indianapolis is a key area of focus for Lilly.  In ...

Patent Expirations Hit Eli Lilly Third Quarter Profit

NEW YORK (AP) — Eli Lilly and Co. said Thursday that its net income and sales sank in the third quarter after its antidepressant Cymbalta lost patent protection and faced competition from less-expe...

Denovo acquires another failed late-stage compound from Lilly

Denovo Biopharma LLC acquired all rights to Eli Lilly & Co.’s schizophrenia candidate pomaglumetad methionil, which Lilly brought into Phase III trials but abandoned after it failed to meet primary ...

Matching PubMed Articles

The 10th Anniversary of the Eli Lilly Chair of Schizophrenia From the University of Montreal.

Efficacy and Safety Extrapolation Analyses for Atomoxetine in Young Children with Attention-Deficit/Hyperactivity Disorder.

Abstract Objectives: This extrapolation analysis qualitatively compared the efficacy and safety profile of atomoxetine from Lilly clinical trial data in 6-7-year-old patients with attention-deficit/hy...

CO2 and SO2 activation by a Cr-Cr quintuple bond.

A quintuply bonded dichromium complex stabilized by aminopyridinato ligands activates CO2 and SO2 by reducing the (formal) bond order of the metal-metal bonds. Oxygen abstraction is observed during CO...

T-Cell Activation, Both Pre- and Post-HAART Levels, Correlates With Carotid Artery Stiffness Over 6.5 Years Among HIV-Infected Women in the WIHS.

T-cell activation is a major pathway driving HIV disease progression. Little is known regarding the impact of T-cell activation on HIV-associated atherosclerosis and cardiovascular disease, a common c...

Complement Alternative Pathway Activation in Human Nonalcoholic Steatohepatitis.

The innate immune system plays a major role in the pathogenesis of nonalcoholic steatohepatitis (NASH). Recently we reported complement activation in human NASH. However, it remained unclear whether t...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement